High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis, and encephalopathy
1998

Understanding 5-Fluorouracil-related Encephalopathy

Sample size: 16 publication Evidence: moderate

Author Information

Author(s): Kun-Huei Yeh, Ann-Lii Cheng

Primary Institution: National Taiwan University Hospital

Hypothesis

Are there distinct mechanisms behind 5-fluorouracil-related encephalopathy?

Conclusion

There are at least two distinct mechanisms for 5-fluorouracil-related encephalopathy, one related to DPD deficiency and another related to 5-FU catabolite accumulation.

Supporting Evidence

  • 5-FU treatment in patients with DPD deficiency usually leads to severe toxicities, which were not observed in the study.
  • Encephalopathy developed at the first exposure in some patients and later in others, indicating different mechanisms.
  • High plasma levels of 5-FU can cause neurological issues due to its accumulation.

Takeaway

Some patients can get sick from a cancer drug called 5-FU because their bodies can't break it down properly, and there are different reasons why this can happen.

Methodology

The study involved observing patients treated with high-dose 5-FU and documenting their reactions and biochemical criteria.

Limitations

The study cannot completely exclude other possible mechanisms for hyperammonaemia.

Participant Demographics

Patients treated with high-dose 5-FU, with some having DPD deficiency.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication